Connect Biopharma Holdings Ltd. (CNTB)
0.7317
-0.05
(-6.25%)
USD |
NASDAQ |
Nov 05, 16:00
0.762
+0.03
(+4.14%)
After-Hours: 07:18
Connect Biopharma Holdings SG&A Expense (TTM) : 13.09M for June 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.09M |
| March 31, 2026 | 8.99M |
| December 31, 2025 | 4.244M |
| Date | Value |
|---|---|
| September 30, 2025 | 0.00 |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Anavex Life Sciences Corp. | 5.935M |
| Vaxcyte, Inc. | 100.22M |
| Foghorn Therapeutics, Inc. | 26.38M |
| Caribou Biosciences, Inc. | 33.74M |
| Arrowhead Pharmaceuticals, Inc. | 172.57M |